Analysts/Institutional Investor Meet/Con. Call Updates

Ref: ADL/SE/2026-27/56 October 28, 2026 To, To, Listing/ Compliance Department Listing/ Compliance Department BSE Limited National Stock Exchange of India Phiroze Jeejeebhoy Towers, Limited, Dalal Street, “Exchange Plaza”, Bandra - Kurla Complex, Mumbai – 400 001 Bandra (E), Mumbai – 400051 NSE SYMBOL: AARTIDRUGS BSE CODE – 524348 Dear Sir/Madam, Ref: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Sub: Intimation of Conference Call This is to inform you that Quarterly Earning Conference Call for the Investors and Analysts have been scheduled on Wednesday, November 4, 2026 at 11:00 A.M. IST to discuss the Company’s financial performance for the Quarter and half year ended September 30, 2026. Please find attached herewith invitation for the same. Kindly take the same on record. Thanking you, Yours faithfully, FOR AARTI DRUGS LIMITED RUSHIKESH DEOLE COMPANY SECRETARY & COMPLIANCE OFFICER ICSI M.No.: F12932 Q2 & H1FY27 Earnings Conference Call PARTICIPANTS Mr. Harshit Savla Jt. Managing Director 4th November 2026 (Wednesday) Mr. Harit Shah Whole time Director Mr. Adhish Patil 11:00 AM, IST Managing Director (HK/Singapore 1:30 PM, UK 6:30 AM, USA 1:30 AM EST) Mr. Vishwa Savla Managing Director, Pinnacle Life Science Private Limited PRE-REGISTERATION LINK Click Here CONFERENCE DIAL-IN DETAILS India +91 22 6280 1309 / +91 22 7115 8210 United States 1 866 746 2133 United Kingdom 0 808 101 1573 Singapore 800 101 2045 Hong Kong 800 964 448 RSVP: Strategic Growth Advisors Pvt. Ltd. Mr. Deven Dhruva | Ms. Krisha Shrimankar + 91 98333 73300 | + 91 87797 99281